{"id":624217,"title":"Draft guidance document: Identifying and labelling medicinal ingredients in new drug products  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-26","captureTimestamp":"2026-02-26T23:23:26.184000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-profile-draft-generic-drug-equivalence/document-2.html","snippet":"Draft Guidance Document: Identifying and Labelling Medicinal Ingredients in New Drug Products This guidance document is being distributed for comment purposes only. Draft date: 2019/04/08 Download the alternative format (PDF format, 252 KB, 11 pages) Foreword Guidance documents…","rawSnapshotUrl":"/api/snapshots/raw/624217","browseUrl":"https://replay.healtharchive.ca/job-6/20260226232326/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-profile-draft-generic-drug-equivalence/document-2.html#ha_snapshot=624217","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}